Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05182164
Title Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas (PEMBROCABOSARC)
Acronym PEMBROCABOSARC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonie RECRUITING Bordeaux 33076 France Details
Centre Georges François Leclerc RECRUITING Dijon 21079 France Details
Centre Oscar Lambret NOT_YET_RECRUITING Lille 59020 France Details
Centre Leon Berard NOT_YET_RECRUITING Lyon 69008 France Details
Institut Paoli Calmettes RECRUITING Marseille 13009 France Details
Hôpital La Timone RECRUITING Marseille 13385 France Details
Institut Curie NOT_YET_RECRUITING Paris 75248 France Details
Institut de Cancérologie de l'Ouest - Site René Gauducheau RECRUITING Saint-Herblain 44805 France Details
IUCT Oncopole NOT_YET_RECRUITING Toulouse 31059 France Details
Institut Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field